HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 205 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,614,941 | -6.9% | 11,218,033 | 0.0% | 98.94% | +0.7% |
| Q2 2023 | $394,762,581 | +7.8% | 11,218,033 | 0.0% | 98.29% | +1.9% |
| Q1 2023 | $366,268,777 | -40.7% | 11,218,033 | 0.0% | 96.46% | -1.1% |
| Q4 2022 | $618,113,619 | +24.4% | 11,218,033 | 0.0% | 97.50% | +2.1% |
| Q3 2022 | $496,847,000 | -9.2% | 11,218,033 | 0.0% | 95.45% | -1.1% |
| Q2 2022 | $547,104,000 | +0.2% | 11,218,033 | 0.0% | 96.54% | +16.0% |
| Q1 2022 | $545,757,000 | -99.9% | 11,218,033 | 0.0% | 83.25% | +9.3% |
| Q4 2021 | $478,337,000,000 | – | 11,218,033 | – | 76.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |